期刊文献+

2种化疗方案治疗晚期上皮性卵巢癌的临床研究 被引量:18

Comparison of efficacy of different chemotherapy regimens in the treatment of advanced epithelial ovarian cancer
在线阅读 下载PDF
导出
摘要 目的探讨不同化学药物治疗(以下简称化疗)方案治疗晚期上皮性卵巢癌的疗效。方法选取2017年7月-2019年6月在海南省第三人民医院就诊的晚期上皮性卵巢癌患者93例,所有患者都是初治且行肿瘤细胞减灭术。术后常规化疗,一组为紫杉醇+卡铂(TC组),另一组为紫杉醇+顺铂(TP组)。比较不同化疗方案对患者的临床疗效及其主要毒副反应。结果TC组有效率为68.9%(31/45),TP组为70.8%(34/48),差异无统计学意义(P>0.05)。TC组骨髓抑制率(48.9%)高于TP组(35.4%)(P<0.05);两组>60岁患者的骨髓抑制率比较,差异无统计学意义(P>0.05)。TP组消化道反应发生率(37.5%)高于TC组(24.4%)(P<0.05)。结论TC和TP方案对晚期上皮性卵巢癌均疗效确切,TP组骨髓抑制发生率低于TC组,TP组虽然总体消化道反应发生率高于TC组,但主要是Ⅰ级和Ⅱ级消化道反应,患者尚可耐受。 Objective To investigate the therapeutic effect of different chemotherapy regimens in the treatment of advanced epithelial ovarian cancer.Methods Ninety-three patients with advanced epithelial ovarian cancer in Hainan Third People’s Hospital from July 2017 to June 2019 were selected and all of them were treated with cytoreductive surgery followed by conventional chemotherapy.According to the different chemotherapy regimens,the patients were divided into TC group(paclitaxel and carboplatin)and TP group(paclitaxel and cisplatin).Clinical efficacy and adverse reactions were assessed after treatment.Results The effective rate was68.9%(31/45)and 70.8%(34/48)in TC group and TP group,respectively,with no significant difference between the groups(P>0.05).The rate of bone marrow suppression in TC group(48.9%)was higher than that in TP group(35.4%)(P<0.05).However,there was no significant difference in the rate of bone marrow suppression in patients older than 60 years between the two groups(P>0.05).Besides,the incidence of gastrointestinal reactions in TP group(37.5%)was higher than that in TC group(24.4%)(P<0.05).Conclusions TC and TP regimens have definite curative effects on advanced epithelial ovarian cancer.TP regimen leads to lower rate of bone marrow suppression in comparison to TC regiment.Although TP regimen induces a higher incidence of gastrointestinal reactions,they are mainly gradeⅠandⅡreactions which are relatively well-tolerated.
作者 张金莲 覃世运 陈美娟 彭芝莲 黄秋雅 王传静 张春花 Jin-lian Zhang;Shi-yun Qin;Mei-juan Chen;Zhi-lian Peng;Qiu-ya Huang;Chuan-jing Wang;Chun-hua Zhang(Hainan Third People's Hospital,Sanya,Hainan 572000,China;Department of Oncology,Xiangya Hospital,Central South University,Changsha,Hunan 410008,China)
出处 《中国现代医学杂志》 CAS 北大核心 2021年第12期79-82,共4页 China Journal of Modern Medicine
关键词 上皮性卵巢癌 晚期 紫杉醇 顺铂 卡铂 化疗后骨髓抑制 消化道反应 advanced epithelial ovarian cancer paclitaxel cisplatin carboplatin bone marrow suppression after chemotherapy gastrointestinal reactions
作者简介 通信作者:张春花,E-mail:573700834@qq.com,Tel:13973175849。
  • 相关文献

参考文献16

二级参考文献102

  • 1张珏,吕加国,朱驹.抗肿瘤药物紫杉醇的化学研究进展[J].中国新药杂志,2006,15(3):178-181. 被引量:13
  • 2石远凯,刘鹏,杨晟,韩晓红,何小慧,艾斌,秦燕,李博,黄鼎智,张长弓,孙燕.注射用聚乙二醇化重组人粒细胞集落刺激因子I期临床耐受性试验[J].癌症,2006,25(4):495-500. 被引量:31
  • 3卜擎燕,熊宁宁,邹建东,蒋萌,刘芳,Anna Zhao-Wong.ICH国际医学用语词典(MedDRA):药事管理的标准医学术语集[J].中国临床药理学与治疗学,2007,12(5):586-590. 被引量:43
  • 42012 NCCN卵巢癌临床实践指南(第二版)[S].2012.
  • 5Pegasus Pharmaceuticals Group Inc.[EB/OL].(2014-10-23).[2014-11-01].http://www.panagin.com/.
  • 6CHMP.Lynparza [EB/OL].(2014-10-23).[2014-11-01].http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/003726/WC500176336.pdf.
  • 7ASCO.The combination of olaparib and cediranib significantly improves progression-free survival in recurrent ovarian cancer [EB/OL].(2014-06-01).[2014-11-01].http://am.asco.org/combination-olaparib-and-cediranib-significantly- improves-progression-free-survival-recurrent.
  • 8吴小华.吴小华谈复发卵巢癌联合靶向治疗试验 [EB/OL].(2014-05-28).[2014-11-01].http://cancer.cmt.com.cn/detail/514317.html.
  • 9许景红.cediranib可改善铂敏感复发性卵巢癌的生存[EB/OL].(2013-10-17).[2014-11-01].http://cancer.cmt.com.cn/detail/341613.html.
  • 10ASCO.A randomised placebo-controlled phase II study of continuous maintenance treatment with BIBF 1120 following chemotherapy in patients with relapsed ovarian cancer [EB/OL].(2014-05-28).[2014-11-01].http://www.clinicaltrials.gov/ct2/show/record/NCT00710762.

共引文献743

同被引文献189

引证文献18

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部